Executive Summary

This report provides a comprehensive investment analysis of Symrise AG, a leading global supplier in the flavors, fragrances, cosmetic ingredients, and functional nutrition markets. As a key player in a consolidated, high-barrier-to-entry industry, Symrise has established itself as a high-quality, defensive growth compounder. The company’s business model is characterized by deep, long-term relationships with a blue-chip customer base, primarily large Fast-Moving Consumer Goods (FMCG) companies, creating significant switching costs and a resilient revenue stream.

Symrise’s long-term success is built upon a robust innovation platform, with new products consistently contributing approximately 15% of annual sales. A key strategic differentiator is its advanced backward integration into the sourcing of natural raw materials, which not only secures supply and manages volatility but also aligns the company with the powerful consumer megatrends of sustainability, traceability, and naturalness. This capability strengthens its competitive moat and makes it a preferred partner for its customers.

Financially, Symrise has a long and impressive track record of delivering above-market organic growth and maintaining strong profitability, typically with EBITDA margins in the 20-22% range. This financial discipline is complemented by a prudent capital allocation strategy that balances organic investments in R&D and capacity, strategic bolt-on acquisitions, and a commitment to consistent shareholder returns, evidenced by 15 consecutive years of dividend increases.

However, the company is navigating a period of significant change. The competitive landscape has been reshaped by large-scale consolidation, notably the merger of DSM and Firmenich, which has intensified competition in the high-growth health and nutrition space. Concurrently, Symrise has faced macroeconomic headwinds, including significant cost inflation that temporarily compressed margins in 2022-2023 and a recent moderation in consumer demand that has led to a downward revision of its 2025 sales forecast.

In response, management has initiated the “ONE Symrise” transformation program, a comprehensive strategy focused on enhancing efficiency, streamlining the portfolio, and fostering greater cross-divisional synergy. Early results are promising, with a strong margin recovery in 2024 and H1 2025, demonstrating the company’s pricing power and operational leverage. The long-term investment thesis hinges on Symrise’s ability to successfully execute this strategy, leveraging its deep-seated competitive advantages to navigate the intensified competitive environment and continue delivering on its long-term growth and profitability targets. The company’s premium valuation reflects its quality, but its performance through this transformative period will be critical in justifying that premium.

Company Overview & Business Model: A Diversified Leader in Sensory and Nutritional Ingredients

Corporate Profile

Symrise AG is a German-headquartered global powerhouse in the development and production of fragrances, flavorings, cosmetic active ingredients, and functional nutrition solutions.¹ With a rich corporate history dating back to 1874, the modern company was formed in 2003 through the merger of Haarmann & Reimer and Dragoco, followed by a successful IPO in 2006.² Today, Symrise is a key constituent of Germany’s benchmark DAX® index.³

The company’s scale is substantial, with revenues reaching approximately €5.0 billion in fiscal year 2024.¹ It employs over 12,700 people worldwide and operates a global network of more than 100 locations.¹ This extensive footprint allows Symrise to serve over 6,000 clients across more than 150 countries.¹ Its vast portfolio comprises over 35,000 products, which are integral components in a wide array of consumer goods, forming what the company describes as an “indispensable part of everyday life”.¹

Core Business Segments

Symrise’s operations are organized into two synergistic segments. This structure, implemented in April 2021, was designed to better align with customer needs and capitalize on operational overlaps in raw materials and production processes.⁶

1. Taste, Nutrition & Health (TN&H): This is the company’s largest segment, generating sales of €2,978 million in 2023.⁷ It provides a comprehensive range of flavors, natural ingredients, and health solutions. Its end markets include food and beverages (covering culinary, snacks, dairy, and sweets), as well as the rapidly growing pet food sector. Within these markets, TN&H holds leading positions, particularly in culinary applications, beverages, and pet food palatability enhancers.⁸
2. Scent & Care (S&C): This segment focuses on the sensory and functional aspects of consumer products, generating sales of €1,752 million in 2023.⁷ It develops and produces fragrances, cosmetic ingredients, and aroma molecules. Key application areas include Fine Fragrances (perfumes), Consumer Fragrances (for personal and home care products), and Oral Care. The S&C segment is a market leader in several specialized and high-value categories, such as oral care ingredients, musk and menthol aroma molecules, micro protection, and sun protection filters.⁸

Revenue & Geographic Profile

Symrise maintains a well-diversified portfolio, balanced across product categories, customer groups, and geographic regions.¹ The company’s global sales distribution in 2022 was EAME (Europe, Africa, Middle East) at 37%, North America at 29%, Asia/Pacific at 21%, and Latin America at 13%.³ A significant component of its growth strategy is its strong presence in high-growth emerging markets. In 2018, these markets accounted for 43% of total sales, providing a long-term tailwind from rising disposable incomes and increasing urbanization.⁹

Business Model Characteristics

Symrise’s business model is built on several key characteristics that create a durable and defensive revenue base.

• B2B Focus & “Brief-to-Contract” Model: The company operates on a business-to-business (B2B) model, partnering closely with its clients—primarily large FMCG companies, food manufacturers, and cosmetic brands—to co-develop new products.¹ The commercial process is typically initiated when a client issues a “brief” for a new flavor or fragrance. Symrise then develops multiple versions, sometimes over 100, to meet the brief’s specifications. Once the client’s internal specialists select a winning formulation, it becomes “core-listed” for the entire lifecycle of the end product.²
• High Switching Costs & Sticky Customer Relationships: This core-listing system is the cornerstone of Symrise’s economic moat. Once a specific flavor or fragrance is integrated into a successful consumer product, such as a globally recognized beverage or shampoo, it becomes a critical part of that product’s brand identity. Changing the supplier is not only technically complex but also commercially risky, as it could alter the sensory profile that consumers know and trust. This creates exceptionally high switching costs and results in very sticky, long-term customer relationships that provide a predictable, recurring revenue stream.²
• Innovation-Driven Cycles: The business is propelled by continuous innovation to meet evolving consumer preferences for new tastes, scents, and functional benefits. Symrise’s robust R&D engine is a critical asset. The company consistently generates approximately 15% of its sales from new product developments (products launched within the last three years), underscoring the vitality and commercial success of its innovation pipeline.⁴

Value Chain Positioning and Integration Strategy

Symrise occupies a highly attractive position within the consumer goods value chain and has pursued a deliberate strategy of vertical integration to fortify its competitive advantages.

• “Sweet Spot” Positioning: The company operates in what can be described as the “sweet spot” of the value chain.² Its ingredients typically represent a very small fraction of an end-product’s total cost, often just 1-5%. However, the flavor or fragrance is a primary driver of the consumer’s purchasing decision and brand loyalty. This dynamic provides Symrise with significant pricing power and insulates it from being treated as a commoditized input, allowing it to capture a disproportionate share of the value it creates.
• Backward Integration as a Strategic Differentiator: A cornerstone of Symrise’s strategy is its increasing backward integration into the sourcing of key natural raw materials.¹ This is a direct response to the growing global demand for natural, traceable, and sustainably sourced ingredients. The company manages an extensive network of approximately 7,000 farmers in Madagascar to secure a sustainable supply of vanilla, one of the world’s most important natural flavors.⁸ Similar long-term partnership programs have been established for mint in India and various botanicals from the Brazilian Amazon.⁸

This strategic emphasis on backward integration serves a dual purpose that extends far beyond simple supply chain management. First, it provides greater control over the supply, quality, and cost of critical inputs, mitigating the volatility inherent in agricultural commodities. Second, and more importantly, it has become a powerful competitive tool. As major FMCG customers face increasing pressure from consumers and regulators to demonstrate the sustainability and traceability of their supply chains, Symrise’s ability to provide fully documented, responsibly sourced natural ingredients becomes a compelling value proposition. This capability allows Symrise to win new business briefs and strengthens its role as an indispensable strategic partner, creating a significant barrier to entry for competitors who lack this level of supply chain control and transparency.

Industry Dynamics & Competitive Landscape: An Oligopoly in Transformation

Global Flavors & Fragrances (F&F) Industry

The F&F industry is a large, structurally attractive market characterized by steady growth and high barriers to entry.

• Size and Growth: The global F&F market size was estimated to be between USD 30 billion and USD 40 billion in 2024-2025.¹³ The industry is projected to grow at a compound annual growth rate (CAGR) of 3.7% to 5.4% through 2030.¹³ This resilient growth is underpinned by non-cyclical demand drivers, including population growth and rising disposable incomes in emerging economies, which fuel demand for processed and convenience foods. Key trends shaping the market include the increasing consumer preference for natural ingredients and innovative new flavor profiles.¹³
• Structure: The industry is a highly concentrated oligopoly.² The four largest players—Givaudan, International Flavors & Fragrances (IFF), dsm-firmenich, and Symrise—collectively controlled over 60% of the market in 2022.¹⁸ This consolidated structure grants incumbents significant advantages in terms of scale, R&D capabilities, purchasing power, and global reach, creating formidable barriers to entry for new competitors.

Adjacent Market Dynamics

Symrise’s growth strategy increasingly involves expanding into adjacent, high-growth markets that leverage its core competencies.

• Cosmetic Ingredients: This market is experiencing robust growth, with a projected CAGR of approximately 5.7%.¹⁹ Growth is fueled by powerful consumer trends such as “clean beauty,” a strong preference for natural and organic formulations, demand for anti-aging and personalized skincare solutions, and a rising focus on sustainability.¹⁹
• Functional Nutrition: The functional foods market, which includes foods offering health benefits beyond basic nutrition, is another high-growth area. The market is forecast to expand at a strong CAGR of 6.5% to 8.5%.²² Key drivers include an aging global population, heightened health consciousness among consumers, and growing demand for products that support specific health goals like immunity, digestive health, and weight management.²³

Competitive Positioning & Market Share

The competitive landscape is dominated by the “Big Four,” each with a distinct strategic posture.

• Givaudan (GIVN.SW): The undisputed market leader, Givaudan reported 2024 sales of CHF 7.4 billion (approximately €7.8 billion) and operates within an expanded market space valued at CHF 42 billion.²⁶ It has historically held a market share of around 25%.²⁸
• dsm-firmenich (DSFIR.AS): Formed in May 2023, this merger created a new industry giant.¹⁸ The combination of DSM’s expertise in health, nutrition, and bioscience with Firmenich’s leadership in perfumery and taste has created a formidable competitor, particularly in the high-growth functional ingredients space where consumer demands for health and sensory experience converge.¹⁸ Prior to the merger, Firmenich held an 11% market share in 2022.¹⁸
• International Flavors & Fragrances (IFF.N): A major U.S.-based player that dramatically increased its scale through the 2021 acquisition of DuPont’s Nutrition & Biosciences division.¹⁸ In 2022, IFF held an estimated market share of 22%.¹⁸ However, the company has faced significant challenges related to the integration of this large acquisition, which has impacted its financial performance and stock valuation.²⁹
• Symrise (SY1.DE): Symrise is the clear number four player, with an estimated market share of approximately 12%.³ The company’s stated strategy is to consistently outperform the underlying market growth of 3-4% through a combination of organic innovation and targeted acquisitions.³²

Industry Consolidation and Symrise’s Strategic Response

The F&F industry has a long history of consolidation, but recent large-scale mergers have fundamentally altered the competitive dynamics.³³ The transformative acquisitions by IFF and the creation of dsm-firmenich have not just increased the scale of Symrise’s main competitors but have also blurred the lines between traditional F&F and the broader health and bioscience industries.

This strategic convergence redefines the competitive battleground. The contest is no longer just about creating the best taste or scent but about delivering integrated solutions that combine sensory appeal with scientifically validated functional benefits, such as improved health, texture, or sustainability profiles. This shift puts immense pressure on all players to broaden their capabilities.

Symrise’s strategic initiatives are a direct and necessary response to this new reality. The “ONE Symrise” transformation program, with its emphasis on fostering cross-divisional synergies between the Taste, Nutrition & Health and Scent & Care segments, is designed to break down internal silos and create a more integrated innovation platform.⁸ The company is also actively streamlining its portfolio, as seen in the planned divestitures of its lower-margin aqua feed and terpene ingredients businesses, to sharpen its focus on higher-growth, higher-margin areas where it can compete most effectively against its larger, newly-integrated rivals.³⁴ The success of this internal transformation will be critical to defending and growing its market share in this more demanding competitive landscape.

Regulatory Environment

The F&F and cosmetic ingredients industries operate within a complex and increasingly stringent global regulatory framework.³⁶ A web of regulations from international bodies and national authorities governs the safety, labeling, and use of ingredients. This regulatory complexity serves as a significant structural barrier to entry, as compliance requires substantial investment in testing, documentation, and legal expertise.² This environment favors large, well-resourced incumbents like Symrise, which possess the global infrastructure and specialized knowledge to navigate these challenges effectively, while making it difficult for smaller, regional players to compete on a global scale.³⁶

Financial Performance & Capital Allocation: A Record of Disciplined Growth

Symrise has demonstrated a long-term track record of disciplined financial management, characterized by consistent growth, strong profitability, and a balanced approach to capital allocation.

---

Table 1: Symrise AG – Selected Financial Data (2015-2024)

Fiscal Year	Sales (€M)	Organic Growth (%)	EBITDA (€M)	EBITDA Margin (%)	Net Income (€M)	EPS (€)	Dividend per Share (€)	Op. Cash Flow (€M)	Capex (€M)	R&D Exp. (€M)	Net Debt (€M)	Net Debt / EBITDA
2015	2,602	6.0%	572	22.0%	247	1.90	0.80	375	147	n/a	1,576	2.8x
2016	2,903	8.0%	625	21.5%	266	2.05	0.85	339	168	n/a	1,971	3.1x
2017	2,996	6.3%	630	21.0%	270	2.08	0.88	396	205	196	1,922	3.0x
2018	3,154	8.8%	631	20.0%	275	2.12	0.90	442	226	200	1,893	3.0x
2019	3,408	n/a	701	20.6%	296	2.20	0.95	547	182	213	2,222	3.2x
2020	3,520	n/a	742	21.1%	307	2.27	0.97	636	159	212	2,029	2.7x
2021	3,826	n/a	814	21.3%	375	2.74	1.02	522	174	221	1,964	2.4x
2022	4,618	n/a	922	20.0%	406	2.91	1.05	360	270	254	2,692	2.9x
2023	4,730	n/a	903	19.1%	340	2.44	1.10	720	270	266	2,666	3.0x
2024	4,999	8.7%	1,033	20.7%	478	3.42	1.20	895	231	276	2,343	2.3x
Note: Data compiled from multiple annual reports and financial releases. EBITDA, Net Income, and EPS are based on normalized/adjusted figures where provided. Net Debt includes pension provisions. R&D data for 2015-2016 is not available in the provided sources. Organic growth data was not consistently reported in all historical periods.
Sources: 3

---

Revenue Growth Trajectory

Symrise has delivered a consistent and robust top-line growth profile over the past decade. From 2015 to 2024, sales grew from €2.6 billion to €5.0 billion, representing a CAGR of approximately 7.5%.⁴ This growth has been achieved through a balanced combination of organic and inorganic expansion.

Organically, the company has consistently outpaced the growth of the underlying F&F market, which typically expands at 3-4% annually.³² For instance, Symrise delivered strong organic growth of 8.8% in 2018 and 8.7% in 2024, demonstrating its ability to gain market share.¹ The company’s long-term ambition is to maintain organic growth in the 5-7% range.¹

However, recent performance reflects a more challenging macroeconomic backdrop. Organic growth moderated to 3.1% in the first half of 2025, prompting management to revise its full-year 2025 guidance downward to a range of 3-5%.³⁵

Profitability Evolution

Symrise has a history of maintaining high and stable profitability.

• Historical Margins: The company has traditionally operated with an EBITDA margin in the target corridor of 20-23%, a hallmark of its strong market position and the value-added nature of its products.⁶
• Margin Compression (2022-2023): Profitability came under significant pressure during the post-pandemic inflationary period. The EBITDA margin contracted to 20.0% in 2022 and further to 19.1% in 2023.³ This compression was primarily driven by a surge in raw material and energy costs, coupled with supply chain inefficiencies and higher operating expenses.
• Margin Recovery (2024-2025): The company has demonstrated a strong and rapid recovery. The EBITDA margin rebounded to 20.7% in 2024.¹ This positive momentum continued into the first half of 2025, where the margin expanded by a notable 100 basis points year-over-year to 21.7%.³⁵ This improvement was driven by successful pricing actions, a favorable product mix, and early benefits from the “ONE Symrise” efficiency program. The gross profit margin also saw a significant 250 basis point improvement in H1 2025, reaching 41.4%.³⁵
• Shift to Value-Led Growth: The margin recovery demonstrates a successful strategic pivot. In a period of slowing volume growth, the company has proven its ability to protect and enhance profitability through pricing power and internal cost discipline. Management’s decision to lower its 2025 sales growth forecast while simultaneously raising its EBITDA margin target to approximately 21.5% is a powerful signal of this focus.³⁵ This indicates that the benefits from efficiency gains and pricing are more than offsetting the impact of a softer demand environment, a characteristic of a well-managed, high-quality business.

Capital Allocation Strategy

Symrise employs a balanced and disciplined capital allocation framework aimed at driving long-term value creation.

• Mergers & Acquisitions (M&A): Symrise has a successful track record of using M&A to enhance its strategic positioning. Notable acquisitions include Diana in 2014 (strengthening its position in natural ingredients and pet food), Pinova/Renessenz in 2016 (expanding its aroma molecules portfolio), and ADF/IDF in 2019 (bolstering its leadership in natural pet food ingredients).² This M&A strategy is focused on acquiring complementary technologies and market access in high-growth areas.
• Capital Expenditures (Capex): The company maintains a disciplined approach to Capex, which has typically ranged from 5-6% of sales. Investments are strategically directed towards capacity expansion in key growth markets. For example, in 2017 and 2018, Capex of €205 million and €226 million, respectively, was primarily allocated to new facilities and capacity upgrades in China and the United States to support future growth.⁹
• Dividend Policy: A core component of Symrise’s shareholder return proposition is its progressive dividend policy. The company has an exceptional track record, with the proposed dividend of €1.20 per share for the 2024 fiscal year marking the 15th consecutive increase.¹ This consistent growth in shareholder returns signals strong management confidence in the company’s long-term cash-generating capabilities.
• R&D Spending: Investment in research and development is non-negotiable and viewed as a critical driver of future growth. R&D expenses are consistently maintained at a level of 5.5-6.0% of sales, amounting to €266 million in 2023 and €276 million in 2024.⁴ This sustained investment is essential to fuel the innovation pipeline that is responsible for generating approximately 15% of total sales from new products.⁴
• Balance Sheet Management: Symrise is committed to maintaining a strong and flexible balance sheet. The company has a stated target for its net debt to EBITDA ratio to remain within a corridor of 2.0x to 2.5x.³⁵ As of the end of the first half of 2025, the leverage ratio stood at 2.4x, comfortably within the target range. This provides the financial flexibility to pursue further organic and inorganic growth opportunities as they arise.³⁵

Growth Opportunities & Strategic Initiatives: The “ONE Symrise” Vision

Symrise’s growth strategy is anchored by its alignment with durable consumer megatrends and is being accelerated by a comprehensive corporate transformation program known as “ONE Symrise.”

Organic Growth Drivers

The company’s diverse portfolio is well-positioned to capitalize on several powerful, long-term consumer trends:

• Health & Wellness: There is a growing global consumer focus on health, driving demand for functional foods and beverages. This is a significant tailwind for the TN&H segment, which provides ingredients for products supporting immunity, digestive health, and overall nutrition.²³
• Natural & Clean Label: The shift towards natural, sustainable, and traceable ingredients is a structural growth driver across both the food and cosmetics industries. Consumers are increasingly scrutinizing product labels and demanding transparency. This trend plays directly to Symrise’s core strengths, particularly its strategic backward integration into natural raw materials, which provides a verifiable and sustainable supply chain.¹³
• Premiumization: In several key categories, consumers are demonstrating a willingness to pay a premium for higher-quality, value-added products. This is particularly evident in the Pet Food market, where the “humanization” of pets drives demand for premium nutrition, and in Fine Fragrances, where brand and quality are paramount.⁸

Strategic Initiatives: The “ONE Symrise” Transformation

“ONE Symrise” is the central pillar of the company’s current strategy. It is a multi-faceted program designed to leverage the company’s global scale, drive performance, and adapt to the evolving competitive landscape.⁸ This program is more than a simple cost-cutting exercise; it represents a fundamental rewiring of the company to create a more agile, integrated, and efficient organization. As the industry consolidates into larger, more integrated players like dsm-firmenich, Symrise’s ability to seamlessly combine the expertise of its different divisions is no longer just an opportunity but a strategic necessity. The “ONE Symrise” program is the blueprint for achieving this integration.

The program is structured around three key pillars:

1. Growth Pillar: This pillar focuses on capturing opportunities in high-growth adjacencies by leveraging cross-divisional knowledge. A prime example is the “ONE CARE” concept, which aims to combine the scientific expertise of the S&C segment (e.g., in skin biology) with the capabilities of the TN&H segment (e.g., in probiotics and nutrition) to create holistic health and beauty solutions, such as “beauty from within” products.⁸
2. Efficiency Pillar: This pillar is designed to deliver tangible financial benefits by leveraging global scale. It targets significant cost savings through optimized global procurement, streamlined asset management, and increased productivity. The program has already proven effective, delivering €50 million in savings in 2024 and targeting an additional €40 million in 2025, which is a direct contributor to the company’s strong margin recovery.³⁵
3. Portfolio Pillar: Symrise is actively managing its business portfolio to sharpen its focus on high-margin, low-capital-intensity activities. The recent strategic decisions to seek alternatives for the terpene ingredients business and to divest the specialized aqua feed business are clear evidence of this disciplined approach to capital allocation in action.³⁴

Innovation and Digitalization

Symrise is at the forefront of applying digital tools to enhance its innovation process. Key initiatives are designed to accelerate development cycles and increase the commercial success rate of new products:

• SymVision AI™: An artificial intelligence platform used to analyze consumer data and predict emerging flavor trends, enabling more targeted and successful product development.⁸
• DigiScent™: A digital tool that allows perfumers and clients to explore and combine elements of the company’s vast fragrance portfolio in a virtual environment, speeding up the creative process.⁸
• Houston Program: A group-wide digital dashboard that allows for the precise tracking of the carbon and water footprint of products and operations, integrating sustainability metrics directly into business and R&D decision-making.⁸

Sustainability as a Competitive Advantage

Symrise has deeply embedded sustainability into its corporate strategy and business model, from raw material sourcing to production processes.⁸ This is not merely a corporate responsibility initiative but a core component of its competitive advantage. Major FMCG clients have their own ambitious sustainability targets and increasingly require their suppliers to demonstrate a commitment to responsible practices. Symrise’s leadership in this area, externally validated by top-tier ratings from organizations like the Carbon Disclosure Project (CDP), where it is on the ‘A List’ for climate and water, and a ‘Gold’ status from EcoVadis, serves as a key differentiator that helps win and retain business with strategic customers.¹¹

Recent Challenges & Headwinds (2022-2024)

Despite its strong long-term track record, Symrise has navigated a series of significant challenges in the recent 2022-2024 period, reflecting a volatile global macroeconomic and geopolitical environment.

• Raw Material & Cost Inflation: The company, along with its industry peers, faced unprecedented cost inflation for raw materials, energy, and logistics during 2022 and 2023. This was the primary factor behind the temporary compression of its EBITDA margin from 21.3% in 2021 to 19.1% in 2023.⁷
• Supply Chain & Inventory Normalization: The post-pandemic period was marked by significant supply chain disruptions, which led many customers to build up safety stocks. As these disruptions eased, the industry entered a period of destocking and inventory normalization. Even in the first half of 2025, Symrise noted that “ongoing market-wide inventory normalization” was a factor affecting performance, particularly in the Aroma Molecules division.⁴²
• Economic Slowdown & Shifting Demand Patterns: A more challenging global demand environment and cautious consumer sentiment were the key reasons cited by management for moderating the full-year 2025 sales guidance.³⁵ This slowdown has not been uniform across the portfolio. The Pet Food division has been a notable area of weakness, posting flat organic sales in H1 2025 due to “cautious consumer sentiment across key markets”.³⁵ This underperformance from what has historically been a high-growth engine was a significant drag on the overall results of the TN&H segment and a key driver of the revised guidance.⁴⁹ The persistent softness in this specific area suggests a more complex dynamic than just general economic caution, potentially reflecting a normalization from unsustainable pandemic-era growth rates, a shift by consumers to lower-priced private-label options, or specific inventory corrections at major customers. The recovery of this division is a critical factor for the company’s near-term growth trajectory.
• Currency Fluctuations: As a global company reporting in Euros, Symrise has significant exposure to currency movements. In the first half of 2025, negative foreign exchange effects reduced reported revenue by €81 million, primarily due to the depreciation of several currencies against the Euro.⁴² Furthermore, in late 2024, the company’s reported organic growth was negatively impacted by accounting adjustments related to hyperinflation in certain markets, which can obscure the underlying performance.⁵⁰
• Regulatory Scrutiny: The concentrated nature of the F&F industry attracts consistent regulatory oversight. In May 2025, Symrise announced that the UK’s Competition & Markets Authority (CMA) had closed an investigation into the company regarding potential anti-competitive agreements. While the closure was a positive development that removed a source of uncertainty, the investigation itself highlights the persistent regulatory risks inherent in the industry.⁴⁴

Segment-Specific Analysis

An analysis of Symrise’s two segments in the first half of 2025 reveals diverging performance drivers, highlighting the benefits of the company’s diversified portfolio.

---

Table 2: Segment Performance – H1 2025 vs. H1 2024

Segment	Reported Revenue H1 2025 (€M)	Organic Growth (%)	EBITDA H1 2025 (€M)	EBITDA Margin (%)
Taste, Nutrition & Health	1,564	3.3%	364	23.3%
Scent & Care	989	2.9%	190	19.2%
Symrise Group Total	2,554	3.1%	554	21.7%
Source: 35

---

Taste, Nutrition & Health (TN&H)

The TN&H segment delivered resilient performance in H1 2025, with organic growth of 3.3% and an impressive 120 basis point expansion in its EBITDA margin to 23.3%.³⁵ This margin strength underscores the segment’s high underlying profitability and the effectiveness of cost control measures.

However, the segment’s performance was a tale of two distinct stories. The Food & Beverage division performed strongly, with mid-single-digit growth driven by double-digit expansion in the Beverages application area.³⁵ This points to robust and resilient consumer demand for at-home consumption products. In stark contrast, the Pet Food division, a key growth engine in prior years, recorded flat organic sales, acting as a significant drag on the segment’s overall growth.³⁵

Strategically, the segment is focused on portfolio optimization to enhance profitability. This is evidenced by the recent divestment of a lower-margin beverage trading business and the planned sale of the aqua feed unit, allowing for a greater focus on high-margin growth opportunities in functional ingredients and natural solutions.³⁵

Scent & Care (S&C)

The S&C segment posted organic growth of 2.9% in H1 2025, with its EBITDA margin improving by a solid 90 basis points to 19.2%.³⁵

The standout performer within this segment was the Fragrance division. It delivered strong growth across all application areas, highlighted by double-digit gains in the high-margin Fine Fragrances business, which benefited from a rebound in social activities and travel.³⁵ The Aroma Molecules division also returned to positive growth as customer destocking trends began to ease. This strength was partially offset by lower sales in the Cosmetic Ingredients division, which faced a very challenging comparison against a strong prior-year period that saw high demand for sun protection products.³⁵

Strategic priorities for the S&C segment include driving premiumization in Fine Fragrances, leveraging AI in fragrance creation to accelerate innovation, and capitalizing on the “clean beauty” trend in cosmetic ingredients. The ongoing strategic review of the terpene ingredients business further demonstrates the company-wide commitment to optimizing the portfolio for higher returns.³⁴

The diverging performance across the segments reveals a “barbell” effect in post-pandemic consumer behavior. Strong spending is evident at both ends of the spectrum: affordable daily essentials (like beverages) and premium discretionary items (like fine fragrances). Meanwhile, categories that saw a surge during the pandemic, such as pet food and certain cosmetic items, are experiencing a period of normalization or consumer trade-down. This pattern underscores the strategic value of Symrise’s diversified portfolio, where strength in some areas can effectively offset temporary weakness in others, leading to overall corporate resilience.

Valuation Considerations: A Premium Asset in a Concentrated Industry

Symrise’s valuation reflects its status as a high-quality, defensive growth company operating within a structurally attractive industry. A comprehensive valuation assessment requires a comparison against its own historical trading ranges and its primary global peers.

---

Table 3: Peer Group Valuation & Fundamentals Comparison

Company	Market Cap	EV/Sales (LTM)	EV/EBITDA (LTM)	P/E (LTM)	Dividend Yield (%)	3-Yr Sales CAGR	EBITDA Margin (LTM)	Net Debt / EBITDA
Symrise AG (SY1.DE)	€10.9B	2.5x	12.0x	21.5x	1.5%	8.8%	20.7%	2.3x
Givaudan (GIVN.SW)	CHF 31.5B	4.6x	19.3x	28.9x	2.1%	7.5%	23.8%	n/a
IFF (IFF.N)	$17.8B	1.9x	12.5x	n/a	2.3%	(1.1)%	15.6%	4.5x
dsm-firmenich (DSFIR.AS)	€21.3B	1.9x	11.8x	29.9x	3.0%	n/a	16.3%	1.8x
Note: Data as of early August 2025. Market data is dynamic. LTM = Last Twelve Months. P/E for IFF is not meaningful due to recent losses. 3-Yr Sales CAGR for dsm-firmenich not applicable due to recent merger.
Sources: 26

---

Current & Historical Multiples

Symrise has consistently commanded a premium valuation relative to the broader market, a reflection of its high-quality and predictable earnings stream, its defensive growth characteristics, and its strong competitive position. The stock currently trades at a price-to-earnings (P/E) ratio of approximately 22x and a price-to-book (P/B) ratio of around 3.0x.⁴⁹ An analysis of these multiples against their 5- and 10-year historical averages is necessary to determine whether the company is trading at a discount or premium to its own established valuation range.

Peer Group Comparison

In the context of its oligopolistic industry, relative valuation is a critical framework.

• Symrise’s valuation is most often benchmarked against Givaudan, the industry leader, which consistently trades at the highest multiples in the sector due to its superior scale and track record.
• Symrise typically trades at a significant premium to IFF, whose valuation has been compressed by the challenges associated with its large-scale acquisition of DuPont’s N&B division, resulting in higher leverage and integration headwinds.
• The valuation comparison with the newly formed dsm-firmenich is still evolving as the market assesses the synergies and execution of the merged entity. Currently, Symrise trades at a slight premium on an EV/EBITDA basis, reflecting its higher and more stable margins.

Key Valuation Drivers

The premium valuation assigned to Symrise is underpinned by several key factors:

1. Consistent Above-Market Organic Growth: The demonstrated ability to grow faster than its underlying markets is a key driver of value.
2. High and Stable Profitability: The defensive nature of its end markets and its strong competitive position allow for high and predictable EBITDA margins.
3. Strong Return on Invested Capital (ROIC): The company’s normalized ROIC of 8.65% indicates efficient and value-accretive use of its capital base.³¹
4. Commitment to Shareholder Returns: The long-standing progressive dividend policy provides a reliable and growing income stream for investors.

Sum-of-the-Parts (SOTP) Analysis

Given the distinct financial profiles of its two segments, a sum-of-the-parts valuation framework is a relevant analytical tool. In H1 2025, the TN&H segment operated at a significantly higher EBITDA margin (23.3%) than the S&C segment (19.2%).³⁵ An SOTP analysis would likely assign a higher valuation multiple to the more profitable TN&H business, which could reveal hidden value or help to justify the overall corporate valuation.

Free Cash Flow & Dividend Sustainability

Management has established a clear and ambitious long-term financial target of delivering Business Free Cash Flow (BFCF) as a percentage of sales of greater than 14%.³ The consistent achievement of this target is fundamental to the company’s ability to self-fund its growth initiatives (Capex and M&A) while continuing to support its progressive dividend. The current dividend payout ratio of approximately 33% is conservative, providing a substantial cushion and ample capacity for future increases, which reinforces the high degree of safety and sustainability of the dividend.⁵⁶

Risk Factors & Long-Term Investment Thesis

Risk Factors

While Symrise possesses a robust business model, it is exposed to several key risks that warrant consideration:

• Raw Material Volatility: The company utilizes approximately 10,000 different raw materials, many of which are agricultural products subject to price volatility due to weather, crop yields, and geopolitical factors.² While its backward integration strategy helps to mitigate this risk, it does not eliminate it entirely.
• Customer Concentration: Although Symrise serves a broad base of over 6,000 customers, a significant portion of its revenue is derived from a concentrated group of large, global FMCG companies. The loss of a key customer or a strategic shift in their sourcing could have a material adverse impact.
• Competitive Threats: The F&F industry is intensely competitive. The recent large-scale consolidation has created larger, more powerful rivals with deeply integrated capabilities. A failure to innovate at pace or to match the integrated solution offerings of peers like dsm-firmenich represents a key strategic risk.¹⁸
• M&A Integration Risk: While Symrise has a strong track record of successfully integrating acquisitions, any future large-scale M&A activity inherently carries execution and integration risks.
• Currency Exposure: With significant revenues and costs denominated in currencies other than the Euro, the company is exposed to material currency translation and transaction risks, which can impact reported financial results.⁴²
• Intellectual Property Protection: The formulations for its ~35,000 products are a core competitive asset. Protecting this vast portfolio of intellectual property from infringement is critical to maintaining its competitive advantage.

Sustainable Competitive Advantages (The Moat)

Symrise’s long-term success is protected by a wide and durable competitive moat built on several pillars:

• Intangible Assets: Decades of accumulated, proprietary knowledge in flavor and fragrance formulation, a world-class R&D organization, and a vast library of scents and tastes that cannot be easily replicated.
• High Switching Costs: The “core list” system, where Symrise’s ingredients are designed into a customer’s product for its entire lifecycle, creates exceptionally high barriers to switching for customers, ensuring revenue stability and predictability.²
• Scale and Global Footprint: The company’s ability to serve the world’s largest consumer brands with globally consistent yet locally tailored solutions is a significant scale advantage that smaller competitors cannot match.
• Backward Integration: This is a unique and increasingly important competitive advantage. It not only secures the supply of critical raw materials but also provides the traceability and sustainability credentials that are now a prerequisite for doing business with leading global customers.¹

Long-Term Investment Thesis

The long-term investment case for Symrise is predicated on its position as a high-quality, defensive growth compounder with a strong competitive moat and a disciplined management team.

• Defensive Growth Compounder: Symrise operates primarily in non-cyclical end markets, providing essential ingredients for food, beverages, and personal care products, which ensures resilient demand through economic cycles. The company is structurally aligned with durable, long-term growth trends, including an aging global population seeking health and nutrition solutions, a growing middle class in emerging markets with increasing disposable income, and the overarching consumer preference for natural, sustainable, and premium products.
• Strong Market Position and Share Gains: As one of the top four players in a consolidated industry with high barriers to entry, Symrise is exceptionally well-positioned to continue gaining market share. Its business model, focused on innovation and deep customer partnerships, has enabled it to consistently deliver organic growth that outpaces the broader market.
• Management Quality and Disciplined Capital Allocation: The management team has demonstrated a clear, consistent, and long-term-oriented strategy. Their approach to capital allocation is disciplined and balanced, effectively deploying cash flow between value-enhancing organic investments (R&D and Capex), strategic M&A, and consistent, growing returns to shareholders via a progressive dividend. The proactive implementation of the “ONE Symrise” program demonstrates an ability to adapt strategically to a changing competitive environment.
• ESG Leadership as a Business Driver: Symrise’s deep integration of sustainability is a core part of its business model, not an afterthought. This leadership enhances its competitive positioning with key customers, mitigates long-term operational and reputational risks, and strengthens its social license to operate.

In conclusion, the investment thesis for Symrise is that of a resilient, high-quality business with multiple durable competitive advantages, poised to compound growth and value over the long term by capitalizing on powerful consumer megatrends. The primary considerations for an investor are whether the company can successfully execute its “ONE Symrise” strategy to navigate the intensified competitive landscape and protect its premium margins and growth profile, and whether its current valuation adequately reflects its superior business quality.

Works cited

1. The most important information for investors – Symrise, accessed August 5, 2025, https://www.symrise.com/investors/
2. Investor Presentation – Symrise, accessed August 5, 2025, https://www.symrise.com/fileadmin/symrise/Corporate/Investors/Financial_calendar_and_presentations/220910-Symrise-IR-Presentation-September-2022.pdf
3. Financial Report 2022 – Annual Reports, accessed August 5, 2025, https://www.annualreports.com/HostedData/AnnualReportArchive/s/symrise-ag_2022.pdf
4. Corporate Report 2024 Sharing Values – Symrise, accessed August 5, 2025, https://symrise.com/corporatereport/2024/home/Symrise_Unternehmensbericht_24_EN_interaktiv_geschuetzt.pdf
5. Our company | Symrise Corporate Report 2023, accessed August 5, 2025, https://symrise.com/corporatereport/2023/company/our-company/index.html
6. 21Financial Report 2021 – Symrise, accessed August 5, 2025, https://symrise.com/corporatereport/2021/downloads/SYM_financialreport_2021_EN.pdf
7. Financial Report 2023 | Symrise, accessed August 5, 2025, https://symrise.com/corporatereport/2023/downloads/SYM_financialreport_2023_EN.pdf
8. Capital Market Day 2024 – Symrise, accessed August 5, 2025, https://www.symrise.com/fileadmin/symrise/Corporate/Investors/Financial_calendar_and_presentations/241120-Symrise-CMD-2024-Presentation.pdf
9. Developing resources – Annual Reports, accessed August 5, 2025, https://www.annualreports.com/HostedData/AnnualReportArchive/s/symrise-ag_2018.pdf
10. Flavors & Fragrance Industry – Sept 2024 FOF, accessed August 5, 2025, https://ppfasfof.com/wp-content/uploads/2024/10/Flavors-Fragrance-Industry-Sept-2024-FOF.pdf
11. Symrise Company Presentation, accessed August 5, 2025, https://www.symrise.com/fileadmin/symrise/Corporate/Investors/Financial_calendar_and_presentations/190528_Presentation_Societe_Generale_The_Nice_Conference.pdf
12. Home | Symrise Corporate Report 2023, accessed August 5, 2025, https://symrise.com/corporatereport/2023/index.html
13. Flavors And Fragrances Market Size, Growth Drivers & Forecast, 2030, accessed August 5, 2025, https://www.mordorintelligence.com/industry-reports/flavor-and-fragrance-market
14. Flavors and Fragrances Market Size, Industry Share Forecast [Latest] – MarketsandMarkets, accessed August 5, 2025, https://www.marketsandmarkets.com/Market-Reports/flavors-fragrance-market-175163912.html
15. Flavors And Fragrances Market Size & Share Report, 2030 – Grand View Research, accessed August 5, 2025, https://www.grandviewresearch.com/industry-analysis/flavors-fragrances-market
16. Flavors and Fragrances Market Size, Demand & Growth by 2033 – Straits Research, accessed August 5, 2025, https://straitsresearch.com/report/flavors-and-fragrances-market
17. The Flavors & Fragrances Industry: More Than Good Scents and Great Tastes, accessed August 5, 2025, https://mbs.rutgers.edu/article/flavors-fragrances-industry-more-good-scents-and-great-tastes
18. Flavors and Fragrance Industry Rivalry Intensifies as DSM and …, accessed August 5, 2025, https://www.eos-intelligence.com/perspectives/consumer-goods-retail/commentary-flavors-and-fragrance-industry-rivalry-intensifies-as-dsm-and-firmenich-join-forces/
19. Cosmetic Ingredients Market Size, Share, Trends & Forecast Report 2034, accessed August 5, 2025, https://www.marketresearchfuture.com/reports/cosmetic-ingredient-market-9827
20. Cosmetic Ingredients Market Size to Reach USD 61.94 Bn By 2034, accessed August 5, 2025, https://www.precedenceresearch.com/cosmetic-ingredients-market
21. Functional Cosmetics And Skin Care Ingredients Market Size & Growth 2032, accessed August 5, 2025, https://www.credenceresearch.com/report/functional-cosmetics-and-skin-care-ingredients-market
22. Functional Food Market Size, Growth and Forecast by 2033 – Straits Research, accessed August 5, 2025, https://straitsresearch.com/report/functional-food-market
23. Functional Foods Market Size & Trends Analysis Report, 2030, accessed August 5, 2025, https://www.grandviewresearch.com/industry-analysis/functional-food-market
24. Functional Food Market Size to Hit USD 671.99 Billion by 2034 – Precedence Research, accessed August 5, 2025, https://www.precedenceresearch.com/functional-food-market
25. Functional food trends, global consumer insights. Mental wellness, accessed August 5, 2025, https://www.innovamarketinsights.com/trends/functional-food-trends-global-consumer-insights/
26. About Givaudan | Givaudan, accessed August 5, 2025, https://www.givaudan.com/our-company/about-givaudan
27. Givaudan – Wikipedia, accessed August 5, 2025, https://en.wikipedia.org/wiki/Givaudan
28. Givaudan – FAIA, accessed August 5, 2025, https://faia.org.uk/givaudan/
29. International Flavors & Fragrances (IFF) Market Cap & Net Worth – Stock Analysis, accessed August 5, 2025, https://stockanalysis.com/stocks/iff/market-cap/
30. Why International Flavors & Fragrances Stock Moved: IFF Stock Has Lost 49% Since 2021 Fiscal End, Primarily Due To Unfavorable Change In Price To Sales Multiple (P/S) | Trefis, accessed August 5, 2025, https://www.trefis.com/data/companies/IFF/no-login-required/GDvB5zkq/Why-International-Flavors-Fragrances-Stock-Moved-IFF-Stock-Has-Lost-49-Since-2021-Fiscal-End-Primarily-Due-To-Unfavorable-Change-In-Price-To-Sales-Multiple-P-S-
31. Symrise AG (SY1) – Morningstar, accessed August 5, 2025, https://www.morningstar.com/stocks/xetr/sy1/quote
32. Symrise successfully continues profitable growth course in 2018 …, accessed August 5, 2025, https://www.symrise.com/newsroom/article/symrise-successfully-continues-profitable-growth-course-in-2018/
33. Flavors and Fragrances Industry Faces Season of Consolidation – ACS Publications, accessed August 5, 2025, https://pubs.acs.org/doi/10.1021/cen-v062n031.p007
34. Symrise I Food & Beverage I Scent & Care I Fragrance – Symrise, accessed August 5, 2025, https://www.symrise.com/
35. Symrise Reports First Half 2025 Results, accessed August 5, 2025, https://www.symrise.com/newsroom/article/symrise-reports-first-half-2025-results/
36. Regulatory frameworks for fragrance safety in cosmetics: a global overview – PubMed, accessed August 5, 2025, https://pubmed.ncbi.nlm.nih.gov/40291114/
37. Flavour and fragrance chemicals, accessed August 5, 2025, https://www.industrialchemicals.gov.au/cosmetics-and-soap/flavour-and-fragrance-chemicals
38. SYM_E 01-51 Lagebericht_160311.indd – Annual Reports, accessed August 5, 2025, https://www.annualreports.com/HostedData/AnnualReportArchive/s/symrise-ag_2015.pdf
39. Symrise fulfills 2017 targets and dynamically starts into current fiscal year, accessed August 5, 2025, https://www.symrise.com/newsroom/article/symrise-fulfills-2017-targets-and-dynamically-starts-into-current-fiscal-year/
40. Diversifying Success. Successfully Diversifying. – Annual Reports, accessed August 5, 2025, https://www.annualreports.com/HostedData/AnnualReportArchive/s/symrise-ag_2016.pdf
41. Results for the Financial Year 2018 – Symrise, accessed August 5, 2025, https://www.symrise.com/fileadmin/symrise/Corporate/Investors/Financial_calendar_and_presentations/SYMRISE_Q4_presentation.pdf
42. Symrise AG (SYIEF) H1 2025 Earnings Call Transcript | Seeking Alpha, accessed August 5, 2025, https://seekingalpha.com/article/4806327-symrise-ag-syief-h1-2025-earnings-call-transcript
43. IR contact – Symrise, accessed August 5, 2025, https://www.symrise.com/investors/ir-contact/
44. Financial and ad hoc news – Symrise, accessed August 5, 2025, https://www.symrise.com/investors/financial-and-ad-hoc-news/
45. Symrise on a profitable growth course in a challenging environment, accessed August 5, 2025, https://www.symrise.com/newsroom/article/?tx_news_pi1%5Bnews%5D=25653&cHash=37f5ff372ecbc47b665e7a46ae5c3a32
46. Sustainability record | Symrise Corporate Report 2023, accessed August 5, 2025, https://symrise.com/corporatereport/2023/company/sustainability-record/
47. Our Highlights 2018 | Symrise Annual Report 2017/18, accessed August 5, 2025, https://m.sh-xhmy.com/cr2018/company/our-highlights-2018
48. Corporate Report 2017 – Unfolding Strengths – Symrise, accessed August 5, 2025, https://www.symrise.com/newsroom/article/corporate-report-2017-unfolding-strengths/
49. Symrise AG Soft topline and guidance reset amid dynamic market. Remains a BUY. – mwb research hub, accessed August 5, 2025, https://downloads.research-hub.de/2025%2007%2031%20Symrise%20Q2%202025%20results___lhwgpzbv.pdf
50. Symrise AG 2024 results on point, stock fairly priced; HOLD., accessed August 5, 2025, https://downloads.research-hub.de/2025%2001%2031%20Symrise%20Q4%202024%20results___fbnpza2x.pdf
51. Givaudan (GIVN.SW) – Market capitalization – Companies Market Cap, accessed August 5, 2025, https://companiesmarketcap.com/givaudan/marketcap/
52. Givaudan SA, GIVN:SWX summary – FT.com – Markets data, accessed August 5, 2025, https://markets.ft.com/data/equities/tearsheet/summary?s=BBG000DB0Q75
53. International Flavors & Fragrances (IFF) – Market capitalization – Companies Market Cap, accessed August 5, 2025, https://companiesmarketcap.com/iff/marketcap/
54. DSM-Firmenich AG (AMS:DSFIR) Market Cap & Net Worth – Stock Analysis, accessed August 5, 2025, https://stockanalysis.com/quote/ams/DSFIR/market-cap/
55. DSM-Firmenich AG, DSFIR:AEX summary – FT.com – Markets data, accessed August 5, 2025, https://markets.ft.com/data/equities/tearsheet/summary?s=DSFIR:AEX
56. ETR:SY1G Financials | Symrise AG – Investing.com, accessed August 5, 2025, https://www.investing.com/equities/symrise-ag-financial-summary
57. Symrise AG Market Cap 2018-2024 | SYIEY – Macrotrends, accessed August 5, 2025, https://www.macrotrends.net/stocks/charts/SYIEY/symrise-ag/market-cap